PRESS RELEASE published on 11/25/2025 at 15:46, 2 months 1 day ago Form 8.3 - The Vanguard Group, Inc.: JTC plc The Vanguard Group, Inc. discloses a 5.06% stake in JTC plc as of 24 Nov 2025. Details include owning 8,696,122 relevant securities and recent purchase/sale transactions Relevant Securities The Vanguard Group Stake Disclosure JTC Plc Purchase/sale Transactions
PRESS RELEASE published on 11/25/2025 at 15:44, 2 months 1 day ago Form 8.3 - The Vanguard Group, Inc.: Avadel Pharmaceuticals plc The Vanguard Group, Inc. discloses 5.72% stake in Avadel Pharmaceuticals plc as of 24 Nov 2025. Details on securities ownership and derivatives The Vanguard Group, Inc. Stake Disclosure Securities Ownership Derivatives Avadel Pharmaceuticals Plc
PRESS RELEASE published on 11/25/2025 at 15:43, 2 months 1 day ago Final Offer Price Notification ISIN XS2999244838 BNP Paribas Issuance B.V. notifies final offer price for unsubordinated notes. Legal documentation available online. AMF approved BNP Paribas Final Offer Price Legal Documentation Unsubordinated Notes AMF Approved
PRESS RELEASE published on 11/25/2025 at 15:42, 2 months 1 day ago Form 8.3 - The Vanguard Group, Inc.: Mural Oncology plc The Vanguard Group, Inc. discloses a 1.41% interest in Mural Oncology plc as of 24 Nov 2025. No other disclosures made Irish Takeover Panel The Vanguard Group Financial Disclosure Interest Disclosure Mural Oncology Plc
PRESS RELEASE published on 11/25/2025 at 15:41, 2 months 1 day ago Form 8.3 - The Vanguard Group, Inc.: Greencore Group plc The Vanguard Group, Inc. discloses 5.33% stake in Greencore Group plc as of 24 Nov 2025. Also making disclosures for Bakkavor Group plc The Vanguard Group, Inc. Financial Disclosure Stake Disclosure Greencore Group Plc Bakkavor Group Plc
PRESS RELEASE published on 11/25/2025 at 15:40, 2 months 1 day ago Form 8.3 - The Vanguard Group, Inc.: Spire Healthcare Group plc The Vanguard Group, Inc. discloses a 3.57% stake in Spire Healthcare Group plc as of 24th November 2025 through Form 8.3 submission Securities Form 8.3 Vanguard Group Stake Disclosure Spire Healthcare Group
PRESS RELEASE published on 11/25/2025 at 15:39, 2 months 1 day ago Form 8.3 - The Vanguard Group, Inc.: Alphawave IP Group plc The Vanguard Group, Inc. discloses 1.80% stake in Alphawave IP Group plc. Dealings include purchasing 5,083 and selling 56,000 1p ordinary shares The Vanguard Group Ownership Disclosure Financial Disclosure Stock Transactions Alphawave IP Group Plc
PRESS RELEASE published on 11/25/2025 at 15:37, 2 months 1 day ago Form 8.3 - The Vanguard Group, Inc.: Dowlais Group plc The Vanguard Group, Inc. discloses ownership of 5.49% in Dowlais Group plc. Additional disclosures regarding American Axle & Manufacturing Holdings, Inc. made Takeover Code Vanguard Group Ownership Disclosure Financial Disclosure Dowlais Group Plc
PRESS RELEASE published on 11/25/2025 at 15:36, 2 months 1 day ago Form 8.3 - The Vanguard Group, Inc.: Petershill Partners plc The Vanguard Group, Inc. discloses 1.11% stake in Petershill Partners plc on 24 Nov 2025. Details in Form 8.3 filing Securities Form 8.3 Disclosure Vanguard Group Petershill Partners
PRESS RELEASE published on 11/25/2025 at 15:35, 2 months 1 day ago Form 8.3 - The Vanguard Group, Inc.: Bakkavor Group plc The Vanguard Group, Inc. discloses a 1.66% stake in Bakkavor Group plc as of 24th November 2025 Vanguard Group Financial Disclosure Stake Disclosure Stock Holdings Bakkavor Group
Published on 01/26/2026 at 19:00, 25 minutes ago Critical Elements Lithium Corp Announces Investor Relations Partnership With Adelaide Capital and Oak Hill Capital
Published on 01/26/2026 at 18:55, 30 minutes ago Kingsmen Resources Announces Upsize of Bought Deal Private Placement to Gross Proceeds of C$11 Million
Published on 01/26/2026 at 15:42, 3 hours 43 minutes ago Greenlane to Deploy up to 30 Million Units of BERA Into Validator Infrastructure to Participate in Protocol-Level Yield Mechanisms, Bringing Total Validator Deployment to up to 50 Million Units
Published on 01/26/2026 at 15:30, 3 hours 55 minutes ago Silver Spruce Announces Director and Officer Resignation
Published on 01/26/2026 at 14:00, 5 hours 25 minutes ago Rare Earth Targets Refined as IP, MT, Radiometric and Geological Data Converge at Colosseum Project
Published on 01/26/2026 at 18:56, 28 minutes ago Fuller, Smith & Turner PLC: Transaction in own shares
Published on 01/26/2026 at 18:41, 44 minutes ago EQS-Adhoc: The Platform Group: Intended Acquisition of the AEP Pharma Group with EUR 1 Billion in Profitable Revenue and a New Independent Business Segment
Published on 01/26/2026 at 18:30, 55 minutes ago DocMorris repurchases convertible bonds maturing in 2026 with a nominal value of around CHF 14.4 million
Published on 01/26/2026 at 17:59, 1 hour 25 minutes ago PoPP draft specifications support seamless continuation of Redcare Pharmacy’s digital e-prescription journey.
Published on 01/26/2026 at 17:45, 1 hour 40 minutes ago Dr. Christian Schlögel nominated as new member of the Board of Directors
Published on 01/26/2026 at 18:00, 1 hour 25 minutes ago Reporting on share buyback transactions carried out between January 20 and January 21, 2026
Published on 01/26/2026 at 17:45, 1 hour 40 minutes ago Gimv increases focus on strategic objectives and discontinues activities for new Life Sciences investments
Published on 01/26/2026 at 17:35, 1 hour 50 minutes ago Disclosure of transactions in own shares from January 19 to January 23, 2026
Published on 01/26/2026 at 08:15, 11 hours 10 minutes ago Signing of the agreement with KPS for the sale of Novacel
